Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Michelle Barron

Concepts (285)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Influenza Vaccines
10
2026
541
1.410
Why?
Influenza, Human
9
2026
634
1.040
Why?
Hospitalization
23
2026
2468
0.860
Why?
Polymerase Chain Reaction
1
2024
1030
0.670
Why?
Ambulatory Care
7
2025
627
0.650
Why?
Mycobacterium tuberculosis
1
2024
325
0.640
Why?
Influenza A Virus, H1N1 Subtype
3
2025
161
0.580
Why?
Hemorrhagic Fever, Ebola
2
2015
82
0.520
Why?
Emergency Service, Hospital
14
2025
2357
0.510
Why?
Vaccines, Inactivated
1
2016
70
0.470
Why?
Vaccines, Attenuated
1
2016
129
0.460
Why?
Pregnancy Complications, Infectious
3
2025
437
0.460
Why?
Viremia
2
2009
158
0.450
Why?
Adult
44
2026
40821
0.430
Why?
Communicable Diseases, Emerging
1
2015
39
0.430
Why?
Staphylococcal Infections
6
2020
396
0.390
Why?
Vaccination
10
2026
1444
0.380
Why?
Middle Aged
37
2026
36359
0.380
Why?
Antifungal Agents
9
2020
153
0.380
Why?
Antibodies, Viral
1
2016
683
0.360
Why?
Hematopoietic Stem Cell Transplantation
2
2009
700
0.340
Why?
Aged
29
2026
26251
0.330
Why?
Dendritic Cells
2
2006
507
0.330
Why?
Case-Control Studies
12
2026
3633
0.320
Why?
Staphylococcus aureus
2
2018
458
0.310
Why?
Serotonin Syndrome
1
2010
4
0.310
Why?
Humans
65
2026
145625
0.310
Why?
Oxazolidinones
1
2010
16
0.310
Why?
Bacteremia
3
2020
218
0.300
Why?
Immunization, Secondary
4
2022
93
0.300
Why?
Acetamides
1
2010
42
0.300
Why?
United States
21
2026
16041
0.290
Why?
Influenza A Virus, H3N2 Subtype
2
2026
50
0.290
Why?
Methicillin
1
2009
10
0.290
Why?
Adaptive Immunity
1
2009
172
0.270
Why?
HIV-1
2
2006
911
0.270
Why?
Female
39
2026
79080
0.270
Why?
Methicillin-Resistant Staphylococcus aureus
4
2020
253
0.270
Why?
Platelet Transfusion
1
2009
76
0.270
Why?
Cytomegalovirus Infections
1
2009
203
0.260
Why?
Male
36
2026
73014
0.260
Why?
Adolescent
21
2026
22451
0.250
Why?
Immunocompromised Host
4
2024
201
0.250
Why?
Anti-Infective Agents
1
2010
234
0.250
Why?
Vitamin K Deficiency
1
2006
9
0.230
Why?
AIDS Vaccines
1
2006
53
0.230
Why?
Rhizopus
1
2005
3
0.220
Why?
Facial Pain
1
2005
12
0.220
Why?
Blood Platelets
1
2009
380
0.220
Why?
Mucormycosis
1
2005
18
0.220
Why?
Vaccines, Synthetic
5
2022
138
0.210
Why?
Cross Infection
3
2014
258
0.210
Why?
Young Adult
16
2026
14240
0.210
Why?
Bone Marrow Transplantation
1
2006
298
0.210
Why?
Respiratory Syncytial Virus Vaccines
1
2024
39
0.200
Why?
Klebsiella Infections
2
2014
26
0.200
Why?
Carbapenems
2
2014
28
0.200
Why?
Chaetomium
1
2003
3
0.200
Why?
Klebsiella pneumoniae
2
2014
48
0.200
Why?
beta-Lactamases
2
2014
54
0.200
Why?
Transplantation, Homologous
1
2005
415
0.200
Why?
Immunity, Innate
1
2009
843
0.200
Why?
Aged, 80 and over
11
2026
8351
0.200
Why?
Petroleum
1
2023
10
0.190
Why?
Petroleum Pollution
1
2023
11
0.190
Why?
Tuberculosis, Pulmonary
1
2024
127
0.190
Why?
Respiratory Syncytial Virus Infections
1
2024
139
0.190
Why?
Mycoses
1
2003
86
0.190
Why?
Candidiasis, Invasive
2
2014
6
0.190
Why?
Sinusitis
1
2005
220
0.180
Why?
Sputum
1
2024
302
0.180
Why?
Brain Diseases
1
2003
157
0.180
Why?
Viral Vaccines
1
2023
107
0.180
Why?
Saccharomyces cerevisiae
1
2006
584
0.170
Why?
Acquired Immunodeficiency Syndrome
1
2002
237
0.170
Why?
Tuberculosis
1
2024
289
0.160
Why?
Pericarditis
1
2020
11
0.160
Why?
Cryptococcus neoformans
1
2020
21
0.160
Why?
Cryptococcosis
1
2020
31
0.150
Why?
Lung Transplantation
2
2013
326
0.150
Why?
Water Pollutants, Chemical
1
2023
227
0.150
Why?
Zygomycosis
2
2009
6
0.150
Why?
Organ Transplantation
3
2020
235
0.150
Why?
Seasons
3
2026
535
0.140
Why?
Nafcillin
1
2018
3
0.140
Why?
Intensive Care Units
5
2021
923
0.140
Why?
Cefazolin
1
2018
22
0.140
Why?
Retrospective Studies
9
2024
17291
0.130
Why?
RNA, Messenger
5
2024
2783
0.130
Why?
Pneumonia
1
2024
633
0.130
Why?
Child, Preschool
8
2026
11888
0.130
Why?
Hemagglutination Inhibition Tests
1
2016
38
0.120
Why?
Disease Outbreaks
3
2015
420
0.120
Why?
Echinocandins
2
2014
8
0.120
Why?
Influenza B virus
2
2026
47
0.120
Why?
North America
1
2016
299
0.110
Why?
Spores, Bacterial
1
2015
18
0.110
Why?
Enterocolitis, Pseudomembranous
1
2015
29
0.110
Why?
Containment of Biohazards
1
2015
23
0.110
Why?
Infectious Disease Transmission, Patient-to-Professional
1
2015
20
0.110
Why?
Mental Disorders
1
2024
1133
0.110
Why?
Anti-Bacterial Agents
4
2020
1935
0.110
Why?
Population Surveillance
2
2015
477
0.110
Why?
Child
9
2026
22638
0.110
Why?
Infant
6
2026
10093
0.110
Why?
Coinfection
1
2016
143
0.100
Why?
Microbial Sensitivity Tests
3
2020
367
0.100
Why?
Renal Replacement Therapy
1
2015
102
0.100
Why?
Bacterial Infections
1
2016
246
0.100
Why?
Pulmonary Aspergillosis
1
2013
4
0.100
Why?
Treatment Outcome
9
2020
11744
0.100
Why?
Immune Reconstitution Inflammatory Syndrome
1
2013
19
0.100
Why?
Heart Transplantation
1
2020
679
0.100
Why?
Virus Diseases
1
2016
219
0.100
Why?
Antibodies, Neutralizing
1
2016
346
0.100
Why?
Secondary Prevention
1
2015
247
0.100
Why?
Vaccines, Combined
2
2023
49
0.100
Why?
Invasive Pulmonary Aspergillosis
1
2013
7
0.100
Why?
Transplantation
1
2013
31
0.090
Why?
Daptomycin
1
2013
18
0.090
Why?
Creatine Kinase
1
2013
70
0.090
Why?
Rectum
1
2014
180
0.090
Why?
Drug Interactions
2
2013
403
0.090
Why?
Risk Factors
8
2024
10840
0.090
Why?
Muscular Diseases
1
2013
110
0.090
Why?
Critical Care
2
2016
700
0.090
Why?
Antiviral Agents
3
2026
774
0.090
Why?
Global Health
1
2015
402
0.090
Why?
Laboratories
2
2021
109
0.080
Why?
Chemoprevention
1
2011
91
0.080
Why?
Sertraline
1
2010
26
0.080
Why?
Graft Rejection
1
2013
504
0.080
Why?
Linezolid
1
2010
25
0.080
Why?
Citalopram
1
2010
33
0.080
Why?
Lung Diseases, Fungal
1
2009
12
0.070
Why?
Tremor
1
2010
98
0.070
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2013
448
0.070
Why?
Hospital Mortality
2
2023
1037
0.070
Why?
Pregnancy
3
2025
7217
0.060
Why?
Sequence Analysis, DNA
2
2024
771
0.060
Why?
Acute Kidney Injury
1
2015
861
0.060
Why?
Newspapers as Topic
1
2006
7
0.060
Why?
Professional Misconduct
1
2006
13
0.060
Why?
Ethics, Research
1
2006
32
0.060
Why?
Lymphocyte Culture Test, Mixed
1
2006
49
0.060
Why?
Hemorrhagic Disorders
1
2006
10
0.060
Why?
Tissue Inhibitor of Metalloproteinase-1
1
2006
26
0.060
Why?
Killer Cells, Natural
1
2009
481
0.060
Why?
Gene Products, gag
1
2006
38
0.060
Why?
Drug Antagonism
1
2006
10
0.060
Why?
Prothrombin Time
1
2006
32
0.060
Why?
Phenytoin
1
2006
21
0.060
Why?
T-Lymphocytes
2
2006
2007
0.060
Why?
Vitamin K
1
2006
46
0.060
Why?
Matrix Metalloproteinase 9
1
2006
128
0.060
Why?
Amphotericin B
1
2005
36
0.050
Why?
Recombination, Genetic
1
2006
202
0.050
Why?
Thrombolytic Therapy
1
2006
165
0.050
Why?
Immunity, Herd
1
2024
7
0.050
Why?
Tissue Plasminogen Activator
1
2006
244
0.050
Why?
Pain
1
2010
787
0.050
Why?
Respiratory Syncytial Virus, Human
1
2024
81
0.050
Why?
Autopsy
1
2003
96
0.050
Why?
Spermine
1
2023
29
0.050
Why?
Oils
1
2023
22
0.050
Why?
Hydrocarbons
1
2023
29
0.050
Why?
Fibrinolytic Agents
1
2006
302
0.050
Why?
Anticonvulsants
1
2006
251
0.050
Why?
B7-2 Antigen
1
2002
27
0.050
Why?
Hodgkin Disease
1
2005
173
0.050
Why?
Time Factors
4
2022
7079
0.050
Why?
Fatal Outcome
1
2003
302
0.050
Why?
Liposomes
1
2005
268
0.050
Why?
RNA, Messenger, Stored
1
2022
7
0.050
Why?
Receptors, CCR5
1
2002
59
0.050
Why?
CD40 Antigens
1
2002
67
0.050
Why?
Receptors, CXCR4
1
2002
90
0.050
Why?
Brain Ischemia
1
2006
362
0.050
Why?
Advisory Committees
1
2024
228
0.050
Why?
Prospective Studies
3
2024
8087
0.040
Why?
Lymphocyte Activation
1
2006
1136
0.040
Why?
HLA-DR Antigens
1
2002
211
0.040
Why?
Vaccination Coverage
1
2023
106
0.040
Why?
Immunophenotyping
1
2002
324
0.040
Why?
Survival Analysis
2
2016
1372
0.040
Why?
Antiretroviral Therapy, Highly Active
1
2002
278
0.040
Why?
Lipopeptides
2
2014
17
0.040
Why?
Pericardiocentesis
1
2020
10
0.040
Why?
Fluconazole
1
2020
24
0.040
Why?
Immunization Schedule
1
2021
186
0.040
Why?
Membrane Glycoproteins
1
2002
495
0.040
Why?
Water
1
2023
451
0.040
Why?
Hospitals
2
2015
730
0.040
Why?
Double-Blind Method
2
2015
2064
0.040
Why?
Antigens, CD
1
2002
559
0.040
Why?
Vancomycin
1
2020
96
0.040
Why?
RNA, Viral
1
2002
691
0.030
Why?
Vascular Grafting
1
2018
14
0.030
Why?
Prevalence
1
2006
2852
0.030
Why?
Cell Proliferation
1
2006
2497
0.030
Why?
Cells, Cultured
1
2006
4112
0.030
Why?
Cytokines
1
2006
2079
0.030
Why?
Endocarditis
1
2018
40
0.030
Why?
Incidence
2
2016
2910
0.030
Why?
Echocardiography
1
2020
645
0.030
Why?
Patient Readmission
1
2021
771
0.030
Why?
Kidney Tubular Necrosis, Acute
1
2015
26
0.030
Why?
Contraindications
1
2015
88
0.030
Why?
Developed Countries
1
2015
38
0.030
Why?
Patient Isolation
1
2015
20
0.030
Why?
Longitudinal Studies
1
2002
3005
0.030
Why?
Africa
1
2015
119
0.030
Why?
Body Fluids
1
2015
70
0.030
Why?
Equipment Contamination
1
2015
67
0.030
Why?
Water-Electrolyte Imbalance
1
2015
38
0.030
Why?
Age Distribution
1
2015
395
0.030
Why?
Systemic Inflammatory Response Syndrome
1
2015
96
0.030
Why?
Ebolavirus
1
2015
91
0.030
Why?
Diarrhea
1
2015
190
0.030
Why?
Travel
1
2015
133
0.030
Why?
Infant, Newborn
2
2016
6449
0.020
Why?
Colorado
2
2014
4588
0.020
Why?
Hospitals, Teaching
1
2014
119
0.020
Why?
Confidence Intervals
1
2014
328
0.020
Why?
Rosuvastatin Calcium
1
2013
21
0.020
Why?
Fluorobenzenes
1
2013
17
0.020
Why?
Allografts
1
2013
148
0.020
Why?
Drug Resistance, Bacterial
1
2014
185
0.020
Why?
Simvastatin
1
2013
58
0.020
Why?
Muscular Dystrophies
1
1992
29
0.020
Why?
Dystrophin
1
1992
40
0.020
Why?
Feces
1
2015
494
0.020
Why?
Recurrence
1
2015
1125
0.020
Why?
APACHE
1
2011
67
0.020
Why?
Diagnosis, Differential
1
2015
1500
0.020
Why?
Pre-Exposure Prophylaxis
1
2014
272
0.020
Why?
Multivariate Analysis
1
2014
1531
0.020
Why?
Comorbidity
1
2015
1652
0.020
Why?
Risk
1
2013
917
0.020
Why?
Logistic Models
1
2015
2112
0.020
Why?
Neoplasms
1
2006
2944
0.020
Why?
Respiration, Artificial
1
2015
711
0.020
Why?
Anticoagulants
1
2015
743
0.020
Why?
Pyrimidines
1
2013
530
0.020
Why?
Patient Care Team
1
2015
700
0.020
Why?
Molecular Epidemiology
1
2009
74
0.020
Why?
Sulfonamides
1
2013
592
0.020
Why?
Delivery of Health Care
1
2015
942
0.020
Why?
DNA, Bacterial
1
2009
319
0.020
Why?
Practice Guidelines as Topic
1
2015
1581
0.020
Why?
Community-Acquired Infections
1
2009
179
0.020
Why?
Los Angeles
1
2006
73
0.020
Why?
Postoperative Complications
2
2009
2962
0.020
Why?
Brain Damage, Chronic
1
2006
17
0.020
Why?
Echo-Planar Imaging
1
2006
24
0.010
Why?
Mass Screening
1
2015
1300
0.010
Why?
Ethics Committees, Research
1
2006
41
0.010
Why?
Enzyme Induction
1
2006
87
0.010
Why?
Convalescence
1
2006
19
0.010
Why?
Drug Approval
1
2006
93
0.010
Why?
Leukocyte Count
1
2006
319
0.010
Why?
Clinical Trials as Topic
1
2011
1062
0.010
Why?
Peptides, Cyclic
1
2006
276
0.010
Why?
Multicenter Studies as Topic
1
2006
413
0.010
Why?
Immunosuppressive Agents
1
2009
824
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2006
845
0.010
Why?
Risk Assessment
1
2013
3678
0.010
Why?
Research
1
2006
421
0.010
Why?
Patient Selection
1
2006
720
0.010
Why?
Lung
1
2013
4119
0.010
Why?
Cohort Studies
1
2009
6045
0.010
Why?
Severity of Illness Index
1
2006
2910
0.010
Why?
Follow-Up Studies
1
2006
5397
0.010
Why?
Biomarkers
1
2006
4329
0.010
Why?
Brain
1
2006
2981
0.010
Why?
DNA Probes
1
1992
57
0.010
Why?
X Chromosome
1
1992
66
0.010
Why?
Chromosomes, Human, Pair 21
1
1992
43
0.010
Why?
Chromosome Deletion
1
1992
126
0.010
Why?
Sex Chromosome Aberrations
1
1992
67
0.010
Why?
Muscles
1
1992
330
0.010
Why?
Exons
1
1992
361
0.010
Why?
Blotting, Western
1
1992
1176
0.000
Why?
Biopsy
1
1992
1073
0.000
Why?
Antibodies, Monoclonal
1
1992
1511
0.000
Why?
Barron's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)